Azisan 40 mg (Tablet)

Unit Price: ৳ 12.00 (3 x 10: ৳ 360.00)
Strip Price: ৳ 120.00

Medicine Details

Category Details
Generic Azilsartan medoxomil
Company Renata limited
Also available as
Azisan 80 mg tablet

Title and Categories

  • Azisan - Angiotensin II Receptor Blocker
  • Antihypertensive Medication
  • Hypertension Treatment
  • Blood Pressure Lowering Drug

Formulation

Oral tablet

Dosage Strengths

  • 20 mg
  • 40 mg
  • 80 mg
  • 120 mg

Dosage Recommendations

The recommended dose in adults is 80 mg taken orally once daily. Consider a starting dose of 40 mg for patients who are treated with high doses of diuretics.

Additional Blood Pressure Reduction

  • Achievable by taking Azisan with other antihypertensive agents

Drug Interactions

  • No interactions observed with amlodipine, antacids, chlorthalidone, digoxin, fluconazole, glyburide, ketoconazole, metformin, pioglitazone, warfarin
  • Potential attenuation of antihypertensive effect by non-steroidal anti-inflammatory drugs including selective COX-2 inhibitors

Contraindications

  • Co-administration of Aliskiren with Azilsartan in patients with diabetes

Most Common Adverse Reaction

Diarrhea

Other Side Effects

  • Nausea
  • Asthenia
  • Fatigue
  • Muscle Spasm
  • Dizziness
  • Cough

Pregnancy Category

Category D

Pregnancy & Lactation

  • Risk to the fetus increases if administered during the second or third trimesters of pregnancy
  • Unknown excretion in human milk, potential adverse effects on nursing infants

Precautions & Warnings

  • Use during the second and third trimesters reduces fetal renal function and increases fetal and neonatal morbidity and death
  • Possible symptomatic hypotension in intravascularly volume-depleted patients
  • Reported changes in renal function including renal failure in renal-impaired patients

Special Populations

  • Pediatric Use: Not established for patients under 18 years of age
  • Geriatric Use: No dose adjustment necessary, but abnormally high serum creatinine values more likely in patients aged 75 years or older
  • Renal Impairment:
    • Dose adjustment not required in patients with mild-to-severe renal impairment or end-stage renal disease
    • Moderate to severe renal impairment more likely to report abnormally high serum creatinine values
  • Hepatic Impairment: Not studied in patients with severe hepatic impairment

Overdose Effects

  • Limited data available in humans
  • Supportive therapy should be instituted based on the patient's clinical status
  • Not dialyzable

Therapeutic Class

Angiotensin-II receptor blocker

Storage Conditions

Keep in a dry place away from light and heat. Keep out of the reach of children.

Related Brands